Very frustrating to see my friends in England will not get access to this drug. About 70 quid per month for 2 years, with robust survival improvements for the highest risk prostate cancers, and a UK research success story.
www.bbc.co.uk/news/article...
#NHS #ProstateCancer #STAMPEDETrialMen denied life-extending pros...
Men denied life-extending prostate cancer drug on NHS in England
NHS England says it cannot afford to offer abiraterone, which is available in Scotland and Wales.
A bonus following my #RedemptionWeek:
I’m highlighting a short paper that can be used for teaching caution in #ClinicalTrial subgroups:
“‘Thursday’s child has far to go’—interpreting subgroups and the #STAMPEDEtrial” https://www.annalsofoncology.org/article/S0923-7534(19)34965-8/fulltext
1/6
McPhail
Matt Sydes